Genentech Adds Patient Assistance Program Along With Avastin Lung Cancer Indication
This article was originally published in The Pink Sheet Daily
Executive Summary
Program similar to Amgen’s for Vectibix.
You may also be interested in...
Genentech Watchers Weigh Deeper Meaning Of Avastin’s Approval
FDA’s breast-cancer decision not a universal surprise, and there’s still risk in RIBBON-1.
Genentech Watchers Weigh Deeper Meaning Of Avastin’s Approval
FDA’s breast-cancer decision not a universal surprise, and there’s still risk in RIBBON-1.
Roche Considers Pricing Flexibility For Avastin In Europe
Similar to Genentech’s price cap on Avastin in the U.S., Roche is evaluating “creative” pricing approaches following breast cancer approval.